Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

CDC advisers voting to decide who gets Covid vaccine first

The vital meeting will be held on Tuesday

Harriet Alexander
Friday 27 November 2020 17:01 EST
Comments
Americans will start receiving Covid vaccines 'by mid-December'

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Scientists and public health experts with the Centers for Disease Control and Prevention (CDC) will vote on Tuesday to decide who will be first people to get a coronavirus vaccine, once one is granted emergency authorisation.

The CDC’s Advisory Committee for Immunization Practices has scheduled an emergency meeting to discuss allocation of Covid-19 vaccines, according to a document obtained by CNN.

It is expected that they will decide healthcare workers will be in the first group, along with those most at risk, such as nursing home residents.

Members of the committee will discuss who should be in the first group, and clinical considerations for the group.

The advisers will also discuss how to monitor safety after allocation of the vaccine, according to the document.

Several vaccines - among them ones made by Pfizer and Moderna - have shown encouraging rates of effectiveness in clinical trials.

They are currently awaiting approval by the Food and Drug Administration (FDA).  The FDA is meeting on 10 December.

Donald Trump said on Thursday that delivery of the coronavirus vaccine would begin next week and the week after.

Speaking to US troops overseas via video link to mark the Thanksgiving holiday, Mr Trump said the vaccine would initially be send to front-line workers, medical personnel and senior citizens.

States were told their allocation of the Pfizer vaccine last week said Gustave Perna, chief operating officer of Operation Warp Speed - the US government’s programme to distribute and administer any vaccine.

He said that individual states were given an estimate of how much they could expect to receive of the 4.1 million initial doses being readied, for when the green light comes.

Training by Pfizer scientists has begun in Rhode Island, New Mexico, Texas and Tennessee to train public health officials in the state on how to handle the vaccine. 

Pfizer’s vaccine must be kept at extremely cold temperatures, which adds to the complications of the mass-vaccination programme.

It is hoped that vaccination can begin before Christmas, with the general population likely to receive their doses around April.

There have been 13 million confirmed cases in the US, and almost 265,000 deaths.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in